Enpp-1-IN-9
Enpp-1-IN-9 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) . The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-9 has the potential for the research of cancer and infectious diseases (extracted from patent WO2021203772A1, compound 51) [1].
Product Specifications
CAS Number
[2718970-70-6]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/enpp-1-in-9.html
Solubility
10 mM in DMSO
Smiles
O=S(OCCC1CCN(CC1)C2=C3C=C(OC)C(OC)=CC3=NC=N2)(N)=O
Molecular Formula
C17H24N4O5S
Molecular Weight
396.46
References & Citations
[1]Bang Fu, et al. Ectonucleotide pyrophosphatase-phosphodiesterase 1 inhibitors, compositions and uses thereof. Patent WO2021203772A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human LPXN shRNA (UAS) - Lentiviral human LPXN shRNA (UAS) (25)
Rabbit anti-Staphylococcus aureus Enterotoxin type G polyclonal Antibody(entG), HRP conjugated
Rabbit anti-Staphylococcus aureus Enterotoxin type G polyclonal Antibody(entG), HRP conjugated